Cargando…

Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: A 14-year Follow-up Study

BACKGROUND: Live-attenuated influenza vaccines (LAIVs) are not licensed in children younger than 2 years of age because of a wheezing safety signal that has not been fully elucidated. In 2000, the Kaiser Permanente Vaccine Study Center conducted a placebo-controlled randomized clinical trial (RCT) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baxter, Roger P., Lewis, Ned, Fireman, Bruce, Hansen, John, Klein, Nicola P., Ortiz, Justin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Williams & Wilkins 2018
Materias:	Original Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847407/ https://www.ncbi.nlm.nih.gov/pubmed/28914750 http://dx.doi.org/10.1097/INF.0000000000001783

Ejemplares similares

2322. Effectiveness of Recombinant Influenza Vaccine vs. Standard Dose Inactivated Influenza Vaccines Against Hospitalized Influenza-Related Outcomes in Adults: A Cluster Randomized Trial
por: Hsiao, Amber, et al.
Publicado: (2022)

Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias
por: Fireman, Bruce, et al.
Publicado: (2009)

Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season
por: Klein, Nicola P., et al.
Publicado: (2020)

LB15. Vaccine Effectiveness of Flucelvax Relative to Inactivated Influenza Vaccine During the 2017–18 Influenza Season in Northern California
por: Klein, Nicola P, et al.
Publicado: (2018)

1047 Use of electronic data to identify new zoster cases for a vaccine effectiveness study
por: Baxter, Roger, et al.
Publicado: (2014)

1078 Risk Factors Associated with Developing Fever Following First Dose Measles-Containing Vaccines
por: Klein, Nicola P., et al.
Publicado: (2014)

22. An Innovative Approach to Examining the Waning of Vaccine Effectiveness Using Automated Healthcare Data
por: Aukes, Laurie, et al.
Publicado: (2021)

2481. Impact of Sex and Race/Ethnicity on the Effectiveness of Live Zoster Vaccine
por: Marks, Morgan A, et al.
Publicado: (2018)

Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records
por: Klein, Nicola P, et al.
Publicado: (2023)

Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study
por: Baxter, Roger, et al.
Publicado: (2018)

2743. Safety of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine in Adults
por: Hansen, John, et al.
Publicado: (2019)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

Population‐based assessment of risks for severe COVID‐19 disease outcomes
por: Zerbo, Ousseny, et al.
Publicado: (2021)

Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
por: Adir, Yochai, et al.
Publicado: (2022)

Association of Birth Defects With Child Mortality Before Age 14 Years
por: Sattolo, Marie-Laure, et al.
Publicado: (2022)

Association of Treated and Untreated Gastroesophageal Reflux Disease in the First Year of Life with the Subsequent Development of Asthma
por: Cantarutti, Anna, et al.
Publicado: (2021)

Prevalence and Severity of Asthma, Rhinitis, and Atopic Eczema in 13- to 14-Year-Old Schoolchildren from Southern Brazil
por: Neto, Arnaldo C Porto, et al.
Publicado: (2006)

Expiratory airflow at 7–8 years of age in children born extremely low birthweight from 14 years before to 14 years after the introduction of exogenous surfactant
por: Doyle, Lex W., et al.
Publicado: (2023)

Antibiotic prescribing across age groups in the Kaiser Permanente Northern California population in association with different diagnoses, and with influenza incidence, 2010–2018
por: Goldstein, Edward, et al.
Publicado: (2022)

Prescribing for different antibiotic classes across age groups in the Kaiser Permanente Northern California population in association with influenza incidence, 2010–2018
por: Goldstein, Edward, et al.
Publicado: (2022)

COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 15, 2021
por: Pingali, Cassandra, et al.
Publicado: (2021)

Possibility of estimating future mutants for influenza: Comparison between previous prediction and subsequent years observation
por: Mao, Tiantian, et al.
Publicado: (2022)

1105 Chronic Kidney Disease and Invasive Pneumococcal Disease in Adults
por: Baxter, Roger, et al.
Publicado: (2014)

Considerations of strategies to provide influenza vaccine year round
por: Lambach, Philipp, et al.
Publicado: (2015)

177. Safety of Measles and Pertussis-containing Vaccines in School-age Children Previously Diagnosed with Autism Spectrum Disorders
por: Zerbo, Ousseny, et al.
Publicado: (2020)

Asthma and subsequent school performance at age 15–16 years: A Swedish population-based sibling control study
por: Lundholm, Cecilia, et al.
Publicado: (2020)

Trends in oral corticosteroids use in severe asthma: a 14-year population-based study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Pneumonia in young adults with asthma: impact on subsequent asthma exacerbations
por: Pelton, Stephen I, et al.
Publicado: (2019)

Perceived fussy eating in Australian children at 14 months of age and subsequent use of maternal feeding practices at 2 years
por: Byrne, Rebecca, et al.
Publicado: (2017)

Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus (HZO)
por: Aukes, Laurie, et al.
Publicado: (2017)

Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16
por: Boddington, Nicki L., et al.
Publicado: (2022)

National Surveillance of Influenza-Associated Encephalopathy in Japan over Six Years, before and during the 2009–2010 Influenza Pandemic
por: Gu, Yoshiaki, et al.
Publicado: (2013)

Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma
por: Turner, Paul J., et al.
Publicado: (2020)

Association between Sedative-hypnotics and Subsequent Cancer in Patients with and without Insomnia: A 14-year Follow-up Study in Taiwan
por: Fang, Hui-Fen, et al.
Publicado: (2019)

Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age
por: Belshe, Robert B., et al.
Publicado: (2010)

The Effectiveness of Conjugate Haemophilus influenzae Type B Vaccine in The Gambia 14 Years After Introduction
por: Howie, Stephen R. C., et al.
Publicado: (2013)

Epidemiology and Burden of Influenza in Children 0–14 Years Over Ten Consecutive Seasons in Italy
por: Barbieri, Elisa, et al.
Publicado: (2023)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)

Use of Electronic Data to Identify Risk Factors Associated with Clostridium difficile Infection (CDI) and to Develop CDI Risk Scores
por: Aukes, Laurie, et al.
Publicado: (2017)

A Risk Score to Predict Clostridioides difficile Infection
por: Aukes, Laurie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3jgrgvg2bucr7cqcop5llu9498